|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01K 67/027 |
| (11) | Patento numeris | 2967014 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14718226.5 |
| Europos patento paraiškos padavimo data | 2014-03-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/023076 |
| Data | 2014-03-11 |
| (87) | Numeris | WO 2014/164640 |
| Data | 2014-10-09 |
| (30) | Numeris | Data | Šalis |
| 201313793812 | 2013-03-11 | US |
| (72) |
MACDONALD, Lynn, US
MURPHY, Andrew J., US
GURER, Cagan, US
MCWHIRTER, John, US
VORONINA, Vera, US
HARRIS, Faith, US
STEVENS, Sean, US
XUE, Yingzi, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS I MOLECULES |
| TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS I MOLECULES |